IL147924A0 - Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents - Google Patents

Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents

Info

Publication number: IL147924A0
Authority: IL; Israel
Prior art keywords: arylmethyl; carbonylamino; antitumor agents; thiazole derivatives; thiazole
Prior art date: 1999-08-12

Application number

IL14792400A

Other languages

English (en)

Original Assignee

Pharmacia Italia Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-12

Filing date

2000-08-11

Publication date

2002-08-14

2000-08-11 Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa

2002-08-14 Publication of IL147924A0 publication Critical patent/IL147924A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Oncology (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

IL14792400A 1999-08-12 2000-08-11 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents IL147924A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/372,832 US6114365A (en)	1999-08-12	1999-08-12	Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
PCT/IB2000/001423 WO2001014353A1 (en)	1999-08-12	2000-08-11	Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents

Publications (1)

Publication Number	Publication Date
IL147924A0 true IL147924A0 (en)	2002-08-14

Family

ID=23469806

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14792400A IL147924A0 (en)	1999-08-12	2000-08-11	Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
IL147924A IL147924A (en)	1999-08-12	2002-01-31	History of Arimethylm - Carbonyl Amino - Thiazole and Their Use in the Treatment of Cultured Diseases Cells Related to Abnormal Kinase Activity

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL147924A IL147924A (en)	1999-08-12	2002-01-31	History of Arimethylm - Carbonyl Amino - Thiazole and Their Use in the Treatment of Cultured Diseases Cells Related to Abnormal Kinase Activity

Country Status (36)

Country	Link
US (3)	US6114365A (ja)
EP (1)	EP1204649B1 (ja)
JP (1)	JP4864260B2 (ja)
KR (2)	KR100773709B1 (ja)
CN (1)	CN100410245C (ja)
AP (1)	AP1853A (ja)
AT (1)	ATE375987T1 (ja)
AU (1)	AU782882B2 (ja)
BG (1)	BG65484B1 (ja)
BR (1)	BR0013281A (ja)
CA (1)	CA2381097C (ja)
CY (1)	CY1107108T1 (ja)
CZ (1)	CZ303138B6 (ja)
DE (1)	DE60036803T2 (ja)
DK (1)	DK1204649T3 (ja)
EA (1)	EA005375B1 (ja)
EE (1)	EE04939B1 (ja)
ES (1)	ES2295056T3 (ja)
GE (1)	GEP20053475B (ja)
HK (1)	HK1054233B (ja)
HR (1)	HRP20020127B1 (ja)
HU (1)	HUP0202492A3 (ja)
IL (2)	IL147924A0 (ja)
IS (1)	IS2594B (ja)
MA (1)	MA25433A1 (ja)
MX (1)	MXPA02001508A (ja)
NO (1)	NO323576B1 (ja)
NZ (1)	NZ517236A (ja)
OA (1)	OA12047A (ja)
PT (1)	PT1204649E (ja)
RS (1)	RS50300B (ja)
SI (1)	SI1204649T1 (ja)
SK (1)	SK287373B6 (ja)
UA (1)	UA72538C2 (ja)
WO (1)	WO2001014353A1 (ja)
ZA (1)	ZA200201117B (ja)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020150921A1 (en) *	1996-02-09	2002-10-17	Francis Barany	Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6407103B2 (en)	1998-04-21	2002-06-18	Bristol-Myers Squibb Pharma Company	Indeno [1,2-c] pyrazol-4-ones and their uses
US6320050B1 (en) *	1999-03-29	2001-11-20	Hoffmann-La Roche Inc.	Heteroaromatic glucokinase activators
US6610846B1 (en) *	1999-03-29	2003-08-26	Hoffman-La Roche Inc.	Heteroaromatic glucokinase activators
US7125875B2 (en) *	1999-04-15	2006-10-24	Bristol-Myers Squibb Company	Cyclic protein tyrosine kinase inhibitors
IL144910A0 (en)	1999-04-15	2002-06-30	Bristol Myers Squibb Co	Cyclic compounds and pharmaceutical compositions containing the same
US6114365A (en) *	1999-08-12	2000-09-05	Pharmacia & Upjohn S.P.A.	Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
EP1229934B1 (en)	1999-10-01	2014-03-05	Immunogen, Inc.	Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US20040048844A1 (en) *	1999-10-20	2004-03-11	Bristol-Myers Squibb Pharma Company	Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
US6291504B1 (en)	1999-10-20	2001-09-18	Dupont Pharmaceuticals Company	Acylsemicarbazides and their uses
CA2430151A1 (en) *	2000-11-27	2002-06-20	Pharmacia Italia S.P.A.	Phenylacetamido- pyrazole derivatives and their use as antitumor agents
US6706718B2 (en) *	2000-12-01	2004-03-16	Bristol-Myers Squibb Company	3-(2,4-dimethylthiazol-5-yl)indeno[1,2-c]pyrazol-4-one derivatives and their uses
CA2430376A1 (en)	2000-12-08	2002-06-13	David J. Carini	Semicarbazides and their uses as cyclin dependent kinase inhibitors
EP1347971B1 (en) *	2000-12-21	2006-03-01	Bristol-Myers Squibb Company	Thiazolyl inhibitors of tec family tyrosine kinases
DE60208630T2 (de) *	2001-05-11	2006-08-17	Pfizer Products Inc., Groton	Thiazolderivate und ihre Verwendung als cdk-Inhibitoren
ATE345341T1 (de) *	2001-07-19	2006-12-15	Pfizer Italia Srl	Phenylacetamido-thiazole verbindungen, verfahren zu ihren herstellung und ihre anwendung als antitumor mittel
EP1724270A3 (en)	2001-07-19	2007-01-03	Pfizer Italia S.r.l.	Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
WO2003027104A1 (en) *	2001-09-27	2003-04-03	Idrtech Inc.	Fumagillol derivatives and preparing method thereof
EP2305648A1 (en) *	2001-12-21	2011-04-06	Novo Nordisk A/S	Amide derivatives useful as glucokinase activators
JP4881559B2 (ja) *	2002-06-27	2012-02-22	ノボ・ノルデイスク・エー／エス	治療薬としてのアリールカルボニル誘導体
EP1594866A1 (en) *	2003-02-12	2005-11-16	Pfizer Inc.	Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives
BRPI0407618A (pt) *	2003-02-21	2006-02-21	Pfizer	derivados de tiazole amino substituidos com cicloalquilo contendo n e composições farmacêuticas para inibição da proliferação celular e métodos para a sua utilização
CA2520957C (en) *	2003-03-31	2013-08-06	Sucampo Ag	Method for treating vascular hyperpermeable disease
FR2857664B1 (fr) *	2003-07-15	2007-12-14	Oreal	Nouveaux derives thiazoles et utilisation de ces derives pour la teinture des fibres keratiniques
WO2005014591A1 (en) *	2003-07-15	2005-02-17	L'oreal	2-acylamino or 2-sulfonylamino-1, 3-thiazoles as couplers for the oxidation dyeing of keratin fibres
US7351727B2 (en) *	2003-09-02	2008-04-01	Bristol-Myers Squibb Company	Inhibitors of 15-lipoxygenase
US20050074424A1 (en) *	2003-10-03	2005-04-07	Lev Salnikov	Using polyion polymers with glucose infusion for a cancer selective chemotherapy compound and method
US20070196395A1 (en) *	2003-12-12	2007-08-23	Mackerell Alexander	Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain
RU2386622C9 (ru) *	2004-01-06	2021-04-21	Ново Нордиск А/С	Гетероароматические производные мочевины и их применение в качестве активаторов глюкокиназы
US20080146555A1 (en)	2004-06-18	2008-06-19	Gpc Biotech, Inc	Uses of Kinase Inhibitors and Compositions Thereof
EP1621539A1 (en) *	2004-07-27	2006-02-01	Aventis Pharma S.A.	Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
EP1621536A1 (en) *	2004-07-27	2006-02-01	Aventis Pharma S.A.	Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
AR050917A1 (es) *	2004-08-13	2006-12-06	Amphora Discovery Corp	Compuestos basados en 2-amido-tiazol que presentan actividad inhibidora de enzimas que utilizan atp, y composiciones y usos de los mismos
ES2327840T3 (es)	2004-12-23	2009-11-04	Gpc Biotech Ag	Derivados de acido escuarico con actividad antiproliferativa.
MX2007015216A (es) *	2005-06-03	2008-02-22	Xenon Pharmaceuticals Inc	Derivados de aminotiazol y sus usos como agentes terapeuticos.
JP2009500378A (ja) *	2005-07-08	2009-01-08	ノボ・ノルデイスク・エー／エス	グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
EP1904467B1 (en) *	2005-07-14	2013-05-01	Novo Nordisk A/S	Urea glucokinase activators
EP1914234A1 (en) *	2006-10-16	2008-04-23	GPC Biotech Inc.	Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors
US8138185B2 (en) *	2007-01-09	2012-03-20	Novo Nordisk A/S	Urea glucokinase activators
WO2008084044A1 (en)	2007-01-11	2008-07-17	Novo Nordisk A/S	Urea glucokinase activators
BRPI0807626B1 (pt) *	2007-02-13	2022-03-03	Ab Science	Processo para a síntese de compostos de 2-aminotiazol como inibidores de quinase
US8450348B2 (en) *	2007-02-21	2013-05-28	Forma Tm, Llc	Derivatives of squaric acid with anti-proliferative activity
TWI437986B (zh) *	2008-01-31	2014-05-21	R Tech Ueno Ltd	噻唑衍生物及使用該衍生物作為ｖａｐ－１抑制劑之用途
US8232402B2 (en)	2008-03-12	2012-07-31	Link Medicine Corporation	Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
EP2112152A1 (en)	2008-04-22	2009-10-28	GPC Biotech AG	Dihydropteridinones as Plk Inhibitors
EP2112150B1 (en)	2008-04-22	2013-10-16	Forma Therapeutics, Inc.	Improved raf inhibitors
US8343996B2 (en)	2008-11-13	2013-01-01	Astrazeneca Ab	Azaquinolinone derivatives and uses thereof
UA103918C2 (en) *	2009-03-02	2013-12-10	Айерем Элелси	N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
TWI504598B (zh) *	2009-03-20	2015-10-21	Onyx Therapeutics Inc	結晶性三肽環氧酮蛋白酶抑制劑
EP2440556A1 (en) *	2009-06-10	2012-04-18	Vertex Pharmaceuticals Incorporated	Inhibitors of phosphatidylinositol 3-kinase
DE102009043260A1 (de) *	2009-09-28	2011-04-28	Merck Patent Gmbh	Pyridinyl-imidazolonderivate
EP2325185A1 (en)	2009-10-28	2011-05-25	GPC Biotech AG	Plk inhibitor
HU0900798D0 (en)	2009-12-21	2010-03-01	Vichem Chemie Kutato Kft	4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
TWI450891B (zh) *	2010-12-29	2014-09-01	Dev Center Biotechnology	新穎微管蛋白抑制劑
RU2011122942A (ru)	2011-06-08	2012-12-20	Общество С Ограниченной Ответственностью "Асинэкс Медхим"	Новые ингибиторы киназ
CN103387551B (zh) *	2012-05-11	2015-05-20	中国人民解放军军事医学科学院毒物药物研究所	噻唑类化合物及其用途
SG10201701438QA (en)	2012-08-23	2017-03-30	Virostatics Srl	Novel 4,6-disubstituted aminopyrimidine derivatives
SG10202004425XA (en)	2016-04-11	2020-06-29	Genfit	Methods of treatment for cholestatic and fibrotic diseases
AU2018380132B2 (en)	2017-12-06	2023-11-09	Lin Bioscience, Inc.	Tubulin inhibitors
CN111741944B (zh) *	2018-02-01	2025-01-03	悉尼大学	抗癌化合物
JP2021526130A (ja)	2018-06-12	2021-09-30	ブイティーブイ・セラピューティクス・エルエルシー	インスリンまたはインスリン類似体と組み合わせたグルコキナーゼ活性化薬の治療的使用
US20220151962A1 (en)	2019-03-22	2022-05-19	Deutsches Krebsforschungszentrum	Novel inhibitors of histone deacetylase 10
EP3712127A1 (en)	2019-03-22	2020-09-23	Deutsches Krebsforschungszentrum	Novel inhibitors of histone deacetylase 10
EP4015506A4 (en) *	2019-09-25	2023-08-30	Korea Institute of Radiological & Medical Sciences	COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING A DERIVATIVE BASED ON TRIFLUOROMETHYLPHENYL PYRAZOLE AS ACTIVE PRINCIPLE
WO2021162054A1 (ja) *	2020-02-10	2021-08-19	学校法人順天堂	２型リアノジン受容体活性抑制剤
CN115322208B (zh) *	2021-05-10	2023-04-11	中国药科大学	2-氨基噻唑类衍生物及其制备方法和医药用途
WO2023182780A1 (ko) *	2022-03-22	2023-09-28	오토텔릭바이오 주식회사	티아졸 유도체 화합물 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL125062C (ja) *	1960-04-20
TW513418B (en) *	1996-07-31	2002-12-11	Otsuka Pharma Co Ltd	Thiazole derivatives, their production and use
JPH1095777A (ja) *	1996-07-31	1998-04-14	Otsuka Pharmaceut Co Ltd	チアゾール誘導体
US6794392B1 (en) *	1996-09-30	2004-09-21	Schering Aktiengesellschaft	Cell differentiation inducer
US6569878B1 (en) *	1997-10-27	2003-05-27	Agouron Pharmaceuticals Inc.	Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
US6040321A (en) *	1997-11-12	2000-03-21	Bristol-Myers Squibb Company	Aminothiazole inhibitors of cyclin dependent kinases
WO1999065884A1 (en) *	1998-06-18	1999-12-23	Bristol-Myers Squibb Company	Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
GB9823871D0 (en) *	1998-10-30	1998-12-23	Pharmacia & Upjohn Spa	2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
IL144910A0 (en) *	1999-04-15	2002-06-30	Bristol Myers Squibb Co	Cyclic compounds and pharmaceutical compositions containing the same
US6114365A (en)	1999-08-12	2000-09-05	Pharmacia & Upjohn S.P.A.	Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
US6992081B2 (en) *	2000-03-23	2006-01-31	Elan Pharmaceuticals, Inc.	Compounds to treat Alzheimer's disease
SE0102440D0 (sv) *	2001-07-05	2001-07-05	Astrazeneca Ab	New compound
EP1321463B1 (en) *	2001-12-21	2007-08-08	Virochem Pharma Inc.	Thiazole derivatives and their use for the treatment or prevention of Flavivirus infections
AR042941A1 (es) *	2003-01-27	2005-07-06	Fujisawa Pharmaceutical Co	Derivados de tiazol, su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos inhibidores de la proteina-1 de adhesion vascular (vap-1)

1999
- 1999-08-12 US US09/372,832 patent/US6114365A/en not_active Expired - Lifetime
2000
- 2000-08-11 US US10/048,474 patent/US6784198B1/en not_active Expired - Fee Related
- 2000-08-11 KR KR1020027001844A patent/KR100773709B1/ko not_active IP Right Cessation
- 2000-08-11 BR BR0013281-0A patent/BR0013281A/pt not_active IP Right Cessation
- 2000-08-11 OA OA1200200052A patent/OA12047A/en unknown
- 2000-08-11 CN CNB008127336A patent/CN100410245C/zh not_active Expired - Fee Related
- 2000-08-11 PT PT00962760T patent/PT1204649E/pt unknown
- 2000-08-11 WO PCT/IB2000/001423 patent/WO2001014353A1/en active IP Right Grant
- 2000-08-11 AT AT00962760T patent/ATE375987T1/de active
- 2000-08-11 JP JP2001518441A patent/JP4864260B2/ja not_active Expired - Fee Related
- 2000-08-11 KR KR1020077014635A patent/KR100827563B1/ko not_active IP Right Cessation
- 2000-08-11 MX MXPA02001508A patent/MXPA02001508A/es active IP Right Grant
- 2000-08-11 AP APAP/P/2002/002441A patent/AP1853A/en active
- 2000-08-11 SK SK180-2002A patent/SK287373B6/sk not_active IP Right Cessation
- 2000-08-11 GE GE4757A patent/GEP20053475B/en unknown
- 2000-08-11 NZ NZ517236A patent/NZ517236A/en not_active IP Right Cessation
- 2000-08-11 AU AU74400/00A patent/AU782882B2/en not_active Ceased
- 2000-08-11 DE DE60036803T patent/DE60036803T2/de not_active Expired - Lifetime
- 2000-08-11 RS YUP-97/02A patent/RS50300B/sr unknown
- 2000-08-11 EP EP00962760A patent/EP1204649B1/en not_active Expired - Lifetime
- 2000-08-11 DK DK00962760T patent/DK1204649T3/da active
- 2000-08-11 HU HU0202492A patent/HUP0202492A3/hu unknown
- 2000-08-11 EE EEP200200064A patent/EE04939B1/xx not_active IP Right Cessation
- 2000-08-11 ES ES00962760T patent/ES2295056T3/es not_active Expired - Lifetime
- 2000-08-11 IL IL14792400A patent/IL147924A0/xx active IP Right Grant
- 2000-08-11 EA EA200200247A patent/EA005375B1/ru not_active IP Right Cessation
- 2000-08-11 CZ CZ20020486A patent/CZ303138B6/cs not_active IP Right Cessation
- 2000-08-11 SI SI200030974T patent/SI1204649T1/sl unknown
- 2000-08-11 CA CA002381097A patent/CA2381097C/en not_active Expired - Fee Related
- 2000-11-08 UA UA2002031948A patent/UA72538C2/uk unknown
2002
- 2002-01-31 IL IL147924A patent/IL147924A/en not_active IP Right Cessation
- 2002-02-08 ZA ZA200201117A patent/ZA200201117B/en unknown
- 2002-02-11 IS IS6264A patent/IS2594B/is unknown
- 2002-02-11 NO NO20020683A patent/NO323576B1/no not_active IP Right Cessation
- 2002-02-12 HR HR20020127A patent/HRP20020127B1/xx not_active IP Right Cessation
- 2002-03-05 BG BG106481A patent/BG65484B1/bg unknown
- 2002-03-11 MA MA26547A patent/MA25433A1/fr unknown
2003
- 2003-09-11 HK HK03106484.7A patent/HK1054233B/zh not_active IP Right Cessation
2004
- 2004-07-29 US US10/902,326 patent/US20050004120A1/en not_active Abandoned
2007
- 2007-12-20 CY CY20071101629T patent/CY1107108T1/el unknown

Also Published As

Publication number	Publication date
US6784198B1 (en)	2004-08-31
DK1204649T3 (da)	2007-12-03
PT1204649E (pt)	2008-01-10
EE04939B1 (et)	2007-12-17
KR100773709B1 (ko)	2007-11-09
AU7440000A (en)	2001-03-19
DE60036803T2 (de)	2008-07-24
AU782882B2 (en)	2005-09-08
AP1853A (en)	2008-05-29
SK1802002A3 (en)	2003-05-02
MA25433A1 (fr)	2002-04-01
BR0013281A (pt)	2002-06-18
IS6264A (is)	2002-02-11
GEP20053475B (en)	2005-03-25
NO20020683L (no)	2002-04-10
EA200200247A1 (ru)	2002-08-29
NZ517236A (en)	2004-11-26
NO323576B1 (no)	2007-06-11
EA005375B1 (ru)	2005-02-24
UA72538C2 (en)	2005-03-15
SK287373B6 (sk)	2010-08-09
SI1204649T1 (sl)	2008-02-29
WO2001014353A1 (en)	2001-03-01
JP2003507461A (ja)	2003-02-25
EE200200064A (et)	2003-04-15
IS2594B (is)	2010-03-15
ZA200201117B (en)	2003-04-30
HUP0202492A2 (hu)	2002-11-28
CN100410245C (zh)	2008-08-13
MXPA02001508A (es)	2003-07-21
KR20070074003A (ko)	2007-07-10
CY1107108T1 (el)	2012-10-24
IL147924A (en)	2008-03-20
EP1204649B1 (en)	2007-10-17
AP2002002441A0 (en)	2002-03-31
CA2381097C (en)	2009-06-16
CZ303138B6 (cs)	2012-04-25
HK1054233A1 (en)	2003-11-21
ES2295056T3 (es)	2008-04-16
CA2381097A1 (en)	2001-03-01
NO20020683D0 (no)	2002-02-11
CN1425009A (zh)	2003-06-18
BG65484B1 (bg)	2008-09-30
KR20020060159A (ko)	2002-07-16
HRP20020127B1 (en)	2010-08-31
KR100827563B1 (ko)	2008-05-07
YU9702A (sh)	2004-11-25
CZ2002486A3 (cs)	2002-11-13
HUP0202492A3 (en)	2004-12-28
PL353588A1 (en)	2003-12-01
HRP20020127A2 (en)	2003-04-30
ATE375987T1 (de)	2007-11-15
US6114365A (en)	2000-09-05
DE60036803D1 (de)	2007-11-29
EP1204649A1 (en)	2002-05-15
JP4864260B2 (ja)	2012-02-01
HK1054233B (zh)	2009-05-29
US20050004120A1 (en)	2005-01-06
OA12047A (en)	2006-05-02
BG106481A (en)	2002-09-30
RS50300B (sr)	2009-09-08

Publication	Publication Date	Title
IL147924A0 (en)	2002-08-14	Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
MXPA03004644A (es)	2003-09-05	Derivados de fenilacetamdia-pirazol y su uso como agentes antitumorales.
IL149374A0 (en)	2002-11-10	New use and novel n-azabicyclo-amide derivatives
EG23817A (en)	2007-09-19	4-Phenyl-pyridine derivatives
PT1296974E (pt)	2009-11-03	Derivados 2-cianopirrolidina e sua utilização como medicamentos
HRP20060251B1 (hr)	2016-08-12	Supstituirani oksazolidinoni i njihova uporaba
IL148167A0 (en)	2002-09-12	Amino-triazolopyridine derivatives
GB0004167D0 (en)	2000-04-12	1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
GC0000183A (en)	2006-03-29	3-Phenyl-pyridine derivatives
IL144637A0 (en)	2002-05-23	Diaryl derivatives and their use as medicaments
EP1194147A4 (en)	2002-10-09	DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE
HUP0201527A3 (en)	2005-01-28	5-phenyl-pyrimidine derivatives
HU0001396D0 (en)	2000-06-28	3-amino-3-arylpropan-1-al derivatives and their use
GC0000191A (en)	2006-03-29	4-Phenyl-pyrimidine derivatives
GB0023323D0 (en)	2000-11-08	Arylhydantoin derivatives and uses thereof
HK1041200A1 (zh)	2002-07-05	化學化合物及其用途
GB9925880D0 (en)	1999-12-29	B-Carboline derivatives
EG26101A (en)	2013-02-17	Derivatives of ethane sulfonyl - piperidine
AU4129800A (en)	2000-11-02	Bis-benzazoles and their use as antineoplastic agents
AP2001002327A0 (en)	2001-12-31	1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives
EP1229913A4 (en)	2005-01-19	SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
PL355845A1 (en)	2004-05-31	Substituted isoquinoline derivatives and their use as inticonvulsants
IL135452A0 (en)	2001-05-20	3-amino-3-arylpropan-1-ol derivatives, their preparation and use
EP1240156A4 (en)	2003-04-16	3-METHYL CHROME OR THIOCHROME DERIVATIVES
GB9929581D0 (en)	2000-02-09	Comjpositions and their use

Legal Events

Date	Code	Title	Description
2008-11-03	FF	Patent granted
2008-11-27	KB	Patent renewed